Activation of Glucagon‐Like Peptide‐1 Receptor Ameliorates Cognitive Decline in Type 2 Diabetes Mellitus Through a Metabolism‐Independent Pathway
出版年份 2021 全文链接
标题
Activation of Glucagon‐Like Peptide‐1 Receptor Ameliorates Cognitive Decline in Type 2 Diabetes Mellitus Through a Metabolism‐Independent Pathway
作者
关键词
-
出版物
Journal of the American Heart Association
Volume 10, Issue 14, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2021-07-10
DOI
10.1161/jaha.120.020734
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study
- (2020) Francesco Vadini et al. INTERNATIONAL JOURNAL OF OBESITY
- Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes
- (2020) Angelo Maria Patti et al. Journal of Clinical Medicine
- Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial
- (2020) Tali Cukierman-Yaffe et al. LANCET NEUROLOGY
- Low‐glucose‐sensitive TRPC6 dysfunction drives hypoglycemia‐induced cognitive impairment in diabetes
- (2020) Chengkang He et al. Clinical and Translational Medicine
- Diabetes Therapies for Dementia
- (2019) Chris Moran et al. Current Neurology and Neuroscience Reports
- Olfactory Dysfunction Mediates Adiposity in Cognitive Impairment of Type 2 Diabetes: Insights From Clinical and Functional Neuroimaging Studies
- (2019) Zhou Zhang et al. DIABETES CARE
- A pilot study of exenatide actions in Alzheimer’s disease
- (2019) Roger J. Mullins et al. Current Alzheimer Research
- Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial
- (2019) Geert Jan Biessels et al. DIABETES CARE
- Evaluation of Neural Degeneration Biomarkers in the Prefrontal Cortex for Early Identification of Patients With Mild Cognitive Impairment: An fNIRS Study
- (2019) Dalin Yang et al. Frontiers in Human Neuroscience
- Glucagon-Like Peptide-1: A Focus on Neurodegenerative Diseases
- (2019) Maddalena Grieco et al. Frontiers in Neuroscience
- Cognitive Impairment and Cardiovascular Disease: A Comparison of Risk Factors, Disability, Quality of Life, and Access to Health Care
- (2019) Mary L. Adams et al. PUBLIC HEALTH REPORTS
- Altered Odor-Induced Brain Activity as an Early Manifestation of Cognitive Decline in Patients With Type 2 Diabetes
- (2018) Zhou Zhang et al. DIABETES
- Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
- (2018) Geert Jan Biessels et al. Nature Reviews Endocrinology
- Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
- (2018) Steven E. Arnold et al. Nature Reviews Neurology
- Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease
- (2018) Miia Kivipelto et al. Nature Reviews Neurology
- Cerebral Hemodynamics in Mild Cognitive Impairment: A Systematic Review
- (2017) Lucy Beishon et al. JOURNAL OF ALZHEIMERS DISEASE
- Blood-Brain Glucose Transfer in Alzheimer’s disease: Effect of GLP-1 Analog Treatment
- (2017) Michael Gejl et al. Scientific Reports
- 2016 Alzheimer's disease facts and figures
- (2016) Alzheimers & Dementia
- Diabetes and Cognitive Impairment
- (2016) Lindsay A. Zilliox et al. Current Diabetes Reports
- Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes
- (2016) Caterina Palleria et al. FRONTIERS IN NEUROENDOCRINOLOGY
- The functional neuroanatomy of verbal memory in Alzheimer’s disease: [18F]-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) correlates of recency and recognition memory
- (2016) Adam M. Staffaroni et al. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
- Exendin-4, a glucagon-like peptide 1 receptor agonist, protects against amyloid-β peptide-induced impairment of spatial learning and memory in rats
- (2016) Xiao-Tao Jia et al. PHYSIOLOGY & BEHAVIOR
- Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment
- (2016) Edo Richard et al. BMJ Open
- In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
- (2016) Michael Gejl et al. Frontiers in Aging Neuroscience
- Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db/db mice
- (2015) De-Lin Ma et al. JOURNAL OF NEUROCHEMISTRY
- Cognitive function in patients with diabetes mellitus: guidance for daily care
- (2015) Paula S Koekkoek et al. LANCET NEUROLOGY
- Mediterranean Diet and Age-Related Cognitive Decline
- (2015) Cinta Valls-Pedret et al. JAMA Internal Medicine
- Diabetes and cognitive dysfunction
- (2012) Rory J McCrimmon et al. LANCET
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
- (2011) P. L. McClean et al. JOURNAL OF NEUROSCIENCE
- Peptide hormones regulating appetite-focus on neuroimaging studies in humans
- (2010) Haiko Schloegl et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- The role of the DLPFC in inductive reasoning of MCI patients and normal agings: An fMRI study
- (2009) YanHui Yang et al. Science in China. Series C, Life sciences / Chinese Academy of Sciences
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started